General MedicationsORALGeneric
CARBAMAZEPINE
CARBAMAZEPINE
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CARBAMAZEPINE is listed in Drugs@FDA under application 201106 (ANDA).
Marketing status: Discontinued Active ingredient CARBAMAZEPINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 300MG Sponsor TARO Submission history Latest submission status date: 2013-06-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview CARBAMAZEPINE is listed in Drugs@FDA under application 201106 (ANDA). Marketing status: Discontinued Active ingredient CARBAMAZEPINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 300MG Sponsor TARO Submission history Latest submission status date: 2013-06-21 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.